Navigation Links
The Government’s Balancing Act on Reservatio

Increasing the reservations on one side and on the other side increasing the number of seats so that general category does not suffer is the UPA Government’s please-all formula//.

The Congress-led alliance and its Left supporters announced that 27 per cent of the seats in Central educational institutions would be available to Other Backward Classes (OBCs) from June 2007. Simultaneously, it has been decided to increase the number of seats so as to ensure that the general category did not lose out.

The Manmohan Singh Government's seriousness in this regard is reflected in the decision to set up an Oversight Committee to draw a time-bound road map on reservation issue, which virtually hijacked the UPA-Left Coordination Committee meeting spread over two sessions to take stock of the two-year performance of the Government. The panel will take into account the recommendations of academicians and administrators before submitting its report by August 31.Besides the Oversight panel, smaller groups consisting of deans, directors and Vice-Chancellors would be constituted to work out details for each class of institutions such as IITs and IIMs.

The meeting also decided that while the Constitution amendment providing for reservation is implemented in letter and in spirit, a bill will be introduce during the monsoon session of Parliament to provide for the quota. The Left parties insisted that the Government sent out a clear message that it was committed to implementing the reservation policy. Even from within the alliance, there was intense pressure for a quick decision on the issue as some southern partners like PMK and DMK even demanded an ordinance so that the issue is not allowed to drag. A votary of reservation, RJD leader Lalu Prasad also pitched in favour of quick implementation of the quota.

At the meeting, the Prime Minister Dr Manmohan Singh circulated a note that said that the number of seats would be increased so that
'"/>




Page: 1 2 3

Related medicine news :

1. Government’s Latest Proposal Under Fire from IM
2. Uproar against the Government’s Proposed Quot
3. Government’s Welfare Plan For Deprived Families Affect Other
4. A Balancing Act: Hormones and the Skin
Post Your Comments:
Breaking Medicine Technology:Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 2Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 3Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 4Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 5Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 6Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 7Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 8Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 9Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4ACCU CHEK 28R 29 Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy com 61955 1ACCU CHEK 28R 29 Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy com 61955 2ACCU CHEK 28R 29 Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy com 61955 3Victory Pharma Inc Announces Launch of NAPRELAN 28R 29 Dose Card 61950 1Victory Pharma Inc Announces Launch of NAPRELAN 28R 29 Dose Card 61950 2Jubilant Organosys UAB and Southern Research Enter Into Drug Discovery Joint Venture 6469 1Jubilant Organosys UAB and Southern Research Enter Into Drug Discovery Joint Venture 6469 2Jubilant Organosys UAB and Southern Research Enter Into Drug Discovery Joint Venture 6469 3Jubilant Organosys UAB and Southern Research Enter Into Drug Discovery Joint Venture 6469 4